STOCK TITAN

Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags

Charles & Colvard, (Nasdaq: CTHR) has responded to a letter from Riverstyx Capital Management regarding director nominations. The company stated that a purported nomination notice from Ben Franklin, a Riverstyx principal, is invalid and will not be recognized. The notice, received on August 27, failed to comply with the company's bylaws by omitting critical information such as candidate biographies, ownership stakes, and candidate consents.

The company's board has invited Mr. Franklin to share his perspectives on the business and strategy directly. Charles & Colvard will make recommendations to shareholders regarding the upcoming Annual Meeting and director elections in due course. Shareholders are not required to take any action at this time.

Charles & Colvard, (Nasdaq: CTHR) ha risposto a una lettera di Riverstyx Capital Management riguardo le nomine per il consiglio di amministrazione. L'azienda ha dichiarato che un presunto avviso di nomina da parte di Ben Franklin, un principale di Riverstyx, è invalido e non sarà riconosciuto. L'avviso, ricevuto il 27 agosto, non ha rispettato le normative aziendali omettendo informazioni cruciali come biografie dei candidati, quote di proprietà e consensi dei candidati.

Il consiglio dell'azienda ha invitato il signor Franklin a condividere le sue prospettive sulla strategia e sull'operatività. Charles & Colvard fornirà raccomandazioni agli azionisti in merito all'imminente Assemblea Annuale e alle elezioni per il consiglio di amministrazione a tempo debito. Gli azionisti non sono tenuti a intraprendere alcuna azione in questo momento.

Charles & Colvard, (Nasdaq: CTHR) ha respondido a una carta de Riverstyx Capital Management sobre nominaciones para el directorio. La compañía declaró que un supuesto aviso de nominación de Ben Franklin, un principal de Riverstyx, es inválido y no será reconocido. El aviso, recibido el 27 de agosto, no cumplió con los estatutos de la empresa al omitir información crítica como biografías de los candidatos, participaciones y consentimientos de los candidatos.

La junta de la compañía ha invitado al Sr. Franklin a compartir sus perspectivas sobre el negocio y la estrategia directamente. Charles & Colvard hará recomendaciones a los accionistas respecto a la próxima Junta Anual y elecciones del directorio a su debido tiempo. No se requiere que los accionistas tomen ninguna acción en este momento.

Charles & Colvard, (Nasdaq: CTHR)는 이사 후보 지명 관련 Riverstyx Capital Management의 서한에 답변했습니다. 회사는 Riverstyx의 주요인 Ben Franklin의 자칭 지명 통지가 무효이며 인정되지 않을 것이라고 밝혔습니다. 8월 27일에 받은 이 통지는 후보자 이력서, 소유 지분 및 후보자 동의서와 같은 중요한 정보를 생략하여 회사의 정관을 준수하지 않았습니다.

회사의 이사회는 프랭클린 씨에게 사업 및 전략에 대한 의견을 직접 공유하도록 초대했습니다. Charles & Colvard는 적절한 시기에 다가오는 연례 회의 및 이사 선거에 대해 주주에게 추천을 제공할 것입니다. 현재 주주들은 어떠한 조치를 취할 필요가 없습니다.

Charles & Colvard, (Nasdaq: CTHR) a répondu à une lettre de Riverstyx Capital Management concernant les nominations au conseil d'administration. La société a déclaré qu'un prétendu avis de nomination de Ben Franklin, un principal de Riverstyx, est invalide et ne sera pas reconnu. L'avis, reçu le 27 août, n'a pas respecté les statuts de l'entreprise en omettant des informations essentielles telles que les biographies des candidats, les participations et les consentements des candidats.

Le conseil d'administration de l'entreprise a invité M. Franklin à partager ses points de vue sur l'entreprise et la stratégie directement. Charles & Colvard fera des recommandations aux actionnaires concernant l'Assemblée Générale à venir et les élections des administrateurs en temps voulu. Les actionnaires ne sont pas tenus de prendre des mesures à ce stade.

Charles & Colvard, (Nasdaq: CTHR) hat auf ein Schreiben von Riverstyx Capital Management bezüglich der Nominierung von Direktoren reagiert. Das Unternehmen erklärte, dass eine angebliche Nominierungsbenachrichtigung von Ben Franklin, einem Hauptvertreter von Riverstyx, ungültig und nicht anerkannt wird. Die am 27. August erhaltene Benachrichtigung erfüllte nicht die Unternehmenssatzung, da sie kritische Informationen wie Lebensläufe der Kandidaten, Eigentumsanteile und Zustimmungen der Kandidaten ausließ.

Der Vorstand des Unternehmens hat Herrn Franklin eingeladen, seine Perspektiven zum Geschäft und zur Strategie direkt zu teilen. Charles & Colvard wird den Aktionären zur gegebenen Zeit Empfehlungen zur bevorstehenden Jahreshauptversammlung und den Direktorwahlen geben. Aktionäre sind derzeit nicht verpflichtet, Maßnahmen zu ergreifen.

Positive
  • None.
Negative
  • None.

Insights

This situation highlights a critical aspect of corporate governance and shareholder rights. The company's rejection of Riverstyx Capital Management's director nominations due to non-compliance with bylaw requirements is a common defensive measure. While it may protect against hasty or ill-prepared nominations, it also raises questions about shareholder access to the board.

The key issues here are:

  • The validity of the nomination process and its alignment with industry standards
  • The balance between shareholder rights and corporate governance procedures
  • The potential for increased shareholder activism or a proxy fight in the future

For investors, this development signals potential internal conflicts and governance challenges. It may lead to increased scrutiny of the current board's performance and strategy. While not immediately impacting financials, it could influence investor sentiment and governance ratings, potentially affecting long-term value.

From a legal perspective, this situation treads a fine line between protecting corporate interests and respecting shareholder rights. The company's bylaws, which require detailed information for director nominations, are generally upheld by courts as valid corporate governance tools. However, the strict enforcement of these rules could be seen as an entrenchment tactic.

Key legal considerations include:

  • The specificity and reasonableness of the bylaw requirements
  • Whether the company applied these rules consistently and fairly
  • The potential for legal challenges by Riverstyx or other shareholders

Investors should be aware that this could lead to litigation, which might be costly and time-consuming for the company. It also raises questions about the board's openness to outside input and could potentially trigger regulatory scrutiny if seen as overly restrictive to shareholder rights.

Notes that Purported Nomination of Director Candidates by a Riverstyx Principal Is Invalid and that the Nominations Will Not be Recognized

RESEARCH TRIANGLE PARK, N.C., Oct. 7, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today commented on a letter sent to the Company's shareholders and released publicly by Riverstyx Capital Management, LLC ("Riverstyx"). The Company provided the following statement in response:

On August 27, Charles & Colvard received a purported notice (the "Notice") from Ben Franklin, a principal of Riverstyx Capital Management, indicating his intention to nominate three candidates to stand for election to Charles & Colvard's Board of Directors (the "Board") at the Company's upcoming Annual Meeting (the "Annual Meeting").

Like most public companies, Charles & Colvard's Bylaws require a shareholder that wishes to nominate candidates for election to provide the Company with advance notice and relevant information regarding the shareholder and its candidates. The aim of such provisions, which numerous courts have recognized as valid, is to ensure that the Board and shareholders have adequate information with which to evaluate candidates and make an informed decision about the nomination and election of directors.

The Notice failed to comply with the clear requirements of the Company's 2011 Amended and Restated Bylaws (the "Bylaws"), which are consistent with the Bylaws of the majority of public companies in relevant respects. Among many other deficiencies, the Notice omitted basic and critical information required by the Bylaws, such as:

    • The biographies and work histories of the candidates;
    • The ownership stakes of the candidates and of the nominating person (Mr. Franklin) and his affiliates and associates, which appear to include various entities that own the Company's stock that are not even mentioned in the Notice; and
    • The consent of each candidate to serve as a director.

After a comprehensive review of the Notice and its deficiencies, and with input from its advisors, the Board today notified Mr. Franklin that the Notice is invalid. Mr. Franklin waited until the day before the last day of the nomination window to deliver the deficient Notice. Accordingly, the Company will not recognize Mr. Franklin's nominations. Any proxies submitted, or votes cast, for the election of Mr. Franklin's candidates will be disregarded.

Charles & Colvard's Board is committed to acting in the best interests of all shareholders and has invited Mr. Franklin to share his perspectives on the Company's business and strategy directly with the Board. The Board and management team look forward to constructively engaging with Mr. Franklin.

Charles & Colvard's Board will make a recommendation to shareholders with respect to the upcoming Annual Meeting and director elections in due course. Charles & Colvard shareholders are not required to take any action at this time.

About Charles & Colvard, Ltd.

Charles & Colvard, Ltd. (Nasdaq: CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, not Mined™ above ground gemstones and a dedication to 100% recycled precious metals. The Company's Forever One™ moissanite and Caydia® lab grown diamond brands provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit https://www.charlesandcolvard.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.

All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; risks related to our ongoing confidential arbitration and relationship with Wolfspeed, Inc.; our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; the execution of our business plans could significantly impact our liquidity; negative or inaccurate information on social media could adversely impact our brand and reputation; our failure to maintain compliance with The Nasdaq Stock Market's continued listing requirements, including filing our U.S. Securities and Exchange Commission ("SEC") reports on a timely basis, could result in the delisting of our common stock; and the other risks and uncertainties described in more detail in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the SEC that discuss other factors relevant to our business.

Important Additional Information Regarding Proxy Solicitation 

Charles & Colvard intends to file a proxy statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for the Company's upcoming Annual Meeting. Charles & Colvard, its directors and certain of its executive officers will be participants in the solicitation of proxies from shareholders in respect of the Annual Meeting. Information regarding the names of Charles & Colvard's directors and executive officers and their respective interests in the Company's securities or otherwise is set forth in the Company's proxy statement for the 2024 Special Meeting of Shareholders, filed with the SEC on April 8, 2024 (the "Special Meeting Proxy Statement"), and the proxy statement for the 2023 Annual Meeting of Shareholders, filed with the SEC on October 27, 2023 (together with the Special Meeting Proxy Statement, the "Prior Proxy Statements"). To the extent holdings of such participants in Charles & Colvard's securities have changed since the amounts described in the Prior Proxy Statements, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Additional information can also be found in the Company's Annual Report on Form 10-K for the year ended June 30, 2023, filed with the SEC on October 12, 2023, and subsequent reports filed by the Company with the SEC. Details concerning the nominees of the Charles & Colvard Board of Directors for election at the upcoming Annual Meeting will be included in the proxy statement to be filed for the Annual Meeting. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SHAREHOLDERS OF CHARLES & COLVARD ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY'S DEFINITIVE PROXY STATEMENT AND ANY AMENDMENTS AND SUPPLEMENTS THERETO ONCE AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. These documents, including the definitive proxy statement (and any amendments or supplements thereto) and other documents filed by Charles & Colvard with the SEC, are or will be available for no charge at the SEC's website at http://www.sec.gov and at Charles & Colvard's investor relations website at https://ir.charlesandcolvard.com/.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-ltd-comments-on-a-letter-from-riverstyx-capital-management-to-charles--colvard-shareholders-302269147.html

SOURCE Charles & Colvard, Ltd.

FAQ

What was Charles & Colvard's (CTHR) response to Riverstyx Capital Management's letter?

Charles & Colvard stated that the purported nomination notice from Ben Franklin, a Riverstyx principal, is invalid and will not be recognized due to non-compliance with the company's bylaws.

Why did Charles & Colvard (CTHR) reject the director nominations from Riverstyx Capital Management?

The nomination notice failed to comply with the company's bylaws by omitting critical information such as candidate biographies, ownership stakes, and candidate consents to serve as directors.

What action are Charles & Colvard (CTHR) shareholders required to take regarding the director nominations?

Charles & Colvard shareholders are not required to take any action at this time. The company will make recommendations regarding the upcoming Annual Meeting and director elections in due course.

How has Charles & Colvard (CTHR) responded to Ben Franklin's attempt to nominate directors?

Charles & Colvard has declared the nomination invalid but has invited Mr. Franklin to share his perspectives on the company's business and strategy directly with the Board.

Charles & Colvard Ltd

NASDAQ:CTHR

CTHR Rankings

CTHR Latest News

CTHR Stock Data

4.10M
1.98M
36.19%
7.26%
1.61%
Luxury Goods
Jewelry, Silverware & Plated Ware
Link
United States of America
MORRISVILLE